The Intermountain Risk Score for Stroke in Patients with Atrial Fibrillation (IMRS-VASc)

Female
Male
Age ≥18 years old
HypertensionCurrent or prior hypertension diagnosis
DiabetesDiabetes
CvaTiaHxPrior CVA/TIA
WarfarinHxCurrent or history of warfarin use
RDWRed Cell Distribution Width (%)
WBCWhite Blood Cell Count (x 103/μL)
GlucoseGlucose (mg/dL)
SodiumSodium (mmol/L)
AlbuminAlbumin
ALTALT (U/L)
AlkPhosAlk Phos
Age ≥18 years old
HypertensionCurrent or prior hypertension diagnosis
DiabetesDiabetes
CvaTiaHxPrior CVA/TIA
WarfarinHxCurrent or history of warfarin use
HCTHematocrit (%)
WBCWhite Blood Cell Count (x 103/μL)
GlucoseGlucose (mg/dL)
PotassiumPotassium (mmol/L)
ALTALT (U/L)

The IMRS-VASc risk score is a predictor of stroke that was derived and validated in patients who have atrial fibrillation, so it applies only to AF patients.
This Risk Calculator is for research purposes only. The information and results are not intended to diagnose, prevent or treat disease. Intermountain Healthcare does not guarantee the accuracy or predictability of the Risk Calculator. For further information about your health, please consult your physician.

Benjamin D. Horne, PhD; Victoria Jacobs, PhD; Heidi T. May, PhD; Kevin G. Graves, MHI; T. Jared Bunch, MD
Augmented intelligence decision tool for stroke prediction combines factors from CHA2DS2‐VASc and the intermountain risk score for patients with atrial fibrillation (IMRS-VASc). Journal of Cardiovascular Electrophysiology


For additional information, please visit: Risk Scores Overview
Risk Score Peer Reviewed Publications